William Wurster, sguardo regionale e architettura come processo

William Wurster (1885 - 1973) works as an architect in the twenties and sixties of the twentieth century. He attends the academic environments of Harvard, Yale, MIT and Berkeley, occupying leading institutional roles. His professional center of gravity is California, but he is known throughout the American continent and in Europe as an architect and university professor. His contacts with intellectuals and urbanists such as Lewis Mumford and Catherine Bauer are close.The contemporary and posthumous critique has presented his work mainly from the historical and typological point of view, without investigating the matrix of thought that underlies it and which, if understood within the Rooseveltian context in which it is shaped, testifies the ability to conduct the value of the architectural project to its process rather than to its form.William Wurster (1885 – 1973) opera come architetto tra gli anni Venti e Sessanta del Novecento. Frequenta gli ambienti accademici di Harvard, Yale, MIT e Berkeley, occupando importanti ruoli istituzionali. Il suo baricentro professionale è la California ma egli è noto in tutto il continente americano e in Europa come architetto e docente universitario. Stretti sono i suoi contatti con intellettuali e urbanisti quali Lewis Mumford e Catherine Bauer.La critica contemporanea e postuma ha presentato la sua opera prevalentemente dal punto di vista storico e tipologico, senza indagare la matrice di pensiero che la sottende e che, se compresa all’interno del contesto roosveltiano in cui si è plasmata, testimonia la capacità di condurre il valore del progetto d’architettura al processo prima che alla form

L'Abuso di informazioni privilegiate: dalle tradizionali problematiche alle nuove prospettive comunitarie

The present research looks at the study and the analysis of the criminal offence of Insider trading. First of all, an outline of the essential issues that lie at the basis of the current Italian regulation is presented, with particular attention to the evolution in legislation and case law of Insider trading in the U.S.. The analysis reviews the most significant steps of such genesis, highlighting any possible connection with the rules currently in force in Italy. Subsequently, the exegesis of the Italian legislation is briefly presented, starting with the basics of European Union law (starting from Directive 89/592/EEC until the most recent Law 62/2005). Then, the present investigation deals with the theories developed in relation to the ratio of the repressive prohibition and to the interest protected by the captioned rule, outlining the various positions resulting from the doctrine and the relationship of the relevant regulation with the s.c. corporate transparency. The investigation continues with the study of what constitutes inside information (Article 181 t.u.f.), focusing on the precise nature of the information and on the price sensitivity. Against this background, the author reaches the core of her research, namely the analysis of the criminal offence of Insider Trading (Articles 184 and 187 bis t.u.f.), highlighting the relevant outstanding issues. Thus, the investigation comes to the comparison with the new administrative offence of Insider trading introduced by Law 62/2005, focusing on the decriminalization of the action of the so-called secondary Insiders. Additionally, the (dual) role of Consob in criminal and administrative proceedings of Insider trading is briefly mentioned. The analysis focuses, in the end, on the new European requirements for reforming the law with a comprehensive view, by way of mentioning, inter alia, a recent intervention of the Court of Justice of the European Union and two measures developed at the end of 2011 by the European Commission (a Proposal for a Directive and a Proposal for a Regulation). The underlying intent of these measures is to dictate the minimum rules of discipline of the phenomenon in the criminal law and to standardize the rules of the Member States of the EU. In conclusion, the author gives an assessment of the current legislation on the basis of its effectiveness and systematic consistency

CCDC80 AND CCDC80-L1: IDENTIFICATION AND FUNCTIONAL ANALYSIS OF TWO NOVEL GENES INVOLVED IN ZEBRAFISH (DANIO RERIO) DEVELOPMENT

The ccdc80 and ccdc80-like1 (ccdc80-l1) genes were isolated in zebrafish in silico, on the basis of their high aminoacidic sequence identity with the human CCDC80 protein (coiled-coil domain containing 80). In human, CCDC80 is involved in several carcinomas, and during recent years it has been proposed as an onco-suppressor gene, increasing the interest in the comprehension of its functions. During my Ph.D., I have been studying the expression patterns and the functions of its zebrafish homologs, in order to gain insights into the processes and the molecular mechanisms in which they are involved. I took advantage of zebrafish as a model system allowing the application of common genetic and biological experimental assays such as PCR, whole mount in situ hybridization and microinjection technique. I investigated ccdc80 and ccdc80-l1 functions during zebrafish embryonic development, finding that they show very different expression patterns and roles. ccdc80 is expressed in the notochord during somitogenesis up to 48 hour post fertilization (hpf). At this stage, it is expressed also in the heart. Instead, at the same developmental stages, ccdc80-l1 is expressed in cranial ganglia, adaxial cells, muscle pioneers and dorsal dermis. These patterns are suggestive of different roles, in fact, the genes are involved in distinct developmental processes, such as somitogenesis and axonal pathfinding, respectively. Functional analysis were obtained performing loss- and gain-of-function experiments. The results clearly demonstrated that manipulation of Ccdc80 protein levels during embryonic development, both increasing and decreasing them, leads to a severe impairment of somites, metameric structures from which several tissues derive, such as muscle. Nevertheless, this phenotype seemed to be recovered at 24 hpf, since at this stage somites no longer showed the same morphological alterations observed previously. By converse, notwithstanding its expression in muscular tissues, loss-of-ccdc80-l1 does not impair somites formation, leading instead to motoneurons axonal migrations defects, capable to affect embryonic motility. Given the external development of the zebrafish embryo, motility is required very soon for prey and escaping predators, and muscle and motoneurons are equally required for a proper motor behavior. Communication and interactions between these two tissues are fundamental for proper muscles innervation and transmission of nervous inputs to be translated in muscular contractions. ccdc80 and ccdc80-l1 may derive from an ancestor gene involved in these processes and, during evolution, may have developed different functions, but still bound to a key process for embryonic viability in the external environment

Practical Recommendations for Optimal Thromboprophylaxis in Patients with COVID-19: A Consensus Statement Based on Available Clinical Trials.

Coronavirus disease 2019 (COVID-19) has been shown to be strongly associated with increased risk for venous thromboembolism events (VTE) mainly in the inpatient but also in the outpatient setting. Pharmacologic thromboprophylaxis has been shown to offer significant benefits in terms of reducing not only VTE events but also mortality, especially in acutely ill patients with COVID-19. Although the main source of evidence is derived from observational studies with several limitations, thromboprophylaxis is currently recommended for all hospitalized patients with acceptable bleeding risk by all national and international guidelines. Recently, high quality data from randomized controlled trials (RCTs) further support the role of thromboprophylaxis and provide insights into the optimal thromboprophylaxis strategy. The aim of this statement is to systematically review all the available evidence derived from RCTs regarding thromboprophylaxis strategies in patients with COVID-19 in different settings (either inpatient or outpatient) and provide evidence-based guidance to practical questions in everyday clinical practice. Clinical questions accompanied by practical recommendations are provided based on data derived from 20 RCTs that were identified and included in the present study. Overall, the main conclusions are: (i) thromboprophylaxis should be administered in all hospitalized patients with COVID-19, (ii) an optimal dose of inpatient thromboprophylaxis is dependent upon the severity of COVID-19, (iii) thromboprophylaxis should be administered on an individualized basis in post-discharge patients with COVID-19 with high thrombotic risk, and (iv) thromboprophylaxis should not be routinely administered in outpatients. Changes regarding the dominant SARS-CoV-2 variants, the wide immunization status (increasing rates of vaccination and reinfections), and the availability of antiviral therapies and monoclonal antibodies might affect the characteristics of patients with COVID-19; thus, future studies will inform us about the thrombotic risk and the optimal therapeutic strategies for these patients

ccdc80-l1 Is Involved in Axon Pathfinding of Zebrafish Motoneurons

Axon pathfinding is a subfield of neural development by which neurons send out axons to reach the correct targets. In particular, motoneurons extend their axons toward skeletal muscles, leading to spontaneous motor activity. In this study, we identified the zebrafish Ccdc80 and Ccdc80-like1 (Ccdc80-l1) proteins in silico on the basis of their high aminoacidic sequence identity with the human CCDC80 (Coiled-Coil Domain Containing 80). We focused on ccdc80-l1 gene that is expressed in nervous and non-nervous tissues, in particular in territories correlated with axonal migration, such as adaxial cells and muscle pioneers. Loss of ccdc80-l1 in zebrafish embryos induced motility issues, although somitogenesis and myogenesis were not impaired. Our results strongly suggest that ccdc80-l1 is involved in axon guidance of primary and secondary motoneurons populations, but not in their proper formation. ccdc80-l1 has a differential role as regards the development of ventral and dorsal motoneurons, and this is consistent with the asymmetric distribution of the transcript. The axonal migration defects observed in ccdc80-l1 loss-of-function embryos are similar to the phenotype of several mutants with altered Hedgehog activity. Indeed, we reported that ccdc80-l1 expression is positively regulated by the Hedgehog pathway in adaxial cells and muscle pioneers. These findings strongly indicate ccdc80-l1 as a down-stream effector of the Hedgehog pathway

Comparison of anticoagulation quality between acenocoumarol and warfarin in patients with mechanical prosthetic heart valves: Insights from the nationwide PLECTRUM study

Vitamin K antagonists are indicated for the thromboprophylaxis in patients with mechanical prosthetic heart valves (MPHV). However, it is unclear whether some differences between acenocoumarol and warfarin in terms of anticoagulation quality do exist. We included 2111 MPHV patients included in the nationwide PLECTRUM registry. We evaluated anticoagulation quality by the time in therapeutic range (TiTR). Factors associated with acenocoumarol use and with low TiTR were investigated by multivariable logistic regression analysis. Mean age was 56.8 ± 12.3 years; 44.6% of patients were women and 395 patients were on acenocoumarol. A multivariable logistic regression analysis showed that patients on acenocoumarol had more comorbidities (i.e., ≥3, odds ratio (OR) 1.443, 95% confidence interval (CI) 1.081-1.927, p = 0.013). The mean TiTR was lower in the acenocoumarol than in the warfarin group (56.1 ± 19.2% vs. 61.6 ± 19.4%, p < 0.001). A higher prevalence of TiTR (<60%, <65%, or <70%) was found in acenocoumarol users than in warfarin ones (p < 0.001 for all comparisons). Acenocoumarol use was associated with low TiTR regardless of the cutoff used at multivariable analysis. A lower TiTR on acenocoumarol was found in all subgroups of patients analyzed according to sex, hypertension, diabetes, age, valve site, atrial fibrillation, and INR range. In conclusion, anticoagulation quality was consistently lower in MPHV patients on acenocoumarol compared to those on warfarin

Precise measurement of the thermal and stellar 54^{54}Fe(n,γn, \gamma)55^{55}Fe cross sections via AMS

The detection of long-lived radionuclides through ultra-sensitive single atom counting via accelerator mass spectrometry (AMS) offers opportunities for precise measurements of neutron capture cross sections, e.g. for nuclear astrophysics. The technique represents a truly complementary approach, completely independent of previous experimental methods. The potential of this technique is highlighted at the example of the $^{54}$Fe($n, \gamma$)$^{55}$Fe reaction. Following a series of irradiations with neutrons from cold and thermal to keV energies, the produced long-lived $^{55}$Fe nuclei ($t_{1/2}=2.744(9)$ yr) were analyzed at the Vienna Environmental Research Accelerator (VERA). A reproducibility of about 1% could be achieved for the detection of $^{55}$Fe, yielding cross section uncertainties of less than 3%. Thus, the new data can serve as anchor points to time-of-flight experiments. We report significantly improved neutron capture cross sections at thermal energy ($\sigma_{th}=2.30\pm0.07$ b) as well as for a quasi-Maxwellian spectrum of $kT=25$ keV ($\sigma=30.3\pm1.2$ mb) and for $E_n=481\pm53$ keV ($\sigma= 6.01\pm0.23$ mb). The new experimental cross sections have been used to deduce improved Maxwellian average cross sections in the temperature regime of the common $s$-process scenarios. The astrophysical impact is discussed using stellar models for low-mass AGB stars